Linked Data API

Show Search Form

Search Results

1132035
star this property registered interest false more like this
star this property date less than 2019-06-13more like thismore than 2019-06-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading General Practitioners more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what the requirements for primary care networks to engage with the local community will be. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris remove filter
star this property uin 264406 more like this
star this property answer
answer
star this property is ministerial correction true more like this
star this property date of answer less than 2019-06-18more like thismore than 2019-06-18
star this property answer text <p><ins class="ministerial"> <p><ins class="ministerial">Primary Care Networks (PCNs) are a new way for primary and community service organisations to work together. For PCNs to be successful they will need to work in partnership with local people and the communities they serve. Legal duties which currently apply to NHS service providers - including general practitioner practices - and commissioners around engagement and consultation will continue to be valid for PCNs.</ins></p></ins></p><p><del class="ministerial">NHS England and NHS Improvement, together with the National Institute for Health and Care Excellence, is developing a ’commercial framework’ setting out the parameters for the commercial approach for medicines in the health service in England.</del></p><p><del class="ministerial">The commercial framework will support a single, transparent, robust and integrated pricing and market access process, and is being tested with and informed through consultation with stakeholders including the Association of the British Pharmaceutical Industry.</del></p><p><del class="ministerial">In preparation for public consultation in the coming months, NHS England is actively engaging with industry trade bodies and health system partners, in the first instance, to outline progress on the development of the commercial framework. The consultation on the draft framework is anticipated to be launched in Quarter 3 2019 with consultation events to be held in Manchester and London, and implementation of the commercial framework is expected to follow.</del></p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-18T16:34:05.507Zmore like thismore than 2019-06-18T16:34:05.507Z
star this property question first ministerially corrected
less than 2019-06-19T08:36:30.617Zmore like thismore than 2019-06-19T08:36:30.617Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property previous answer version
123829
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1132037
star this property registered interest false more like this
star this property date less than 2019-06-13more like thismore than 2019-06-13
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading General Practitioners: Rural Areas more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what population exceptions are in place for Primary Care Networks covering large rural and remote areas. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris remove filter
star this property uin 264408 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-18more like thismore than 2019-06-18
star this property answer text <p>NHS England has allowed rurality as an exception for meeting the definition of a Primary Care Network (PCN). As set out in the Network Contract Direct Enhanced Service (under paragraph 3.2) commissioners may waiver the 30,000-minimum population “where a PCN serves a natural community which has a low population density across a large rural and remote area”.</p><p>Further information is available at the following link:</p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/network-contract-des-specification-2019-20-v1.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/network-contract-des-specification-2019-20-v1.pdf</a></p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-18T16:30:48.273Zmore like thismore than 2019-06-18T16:30:48.273Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1125380
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to the Health Service Products (Provision and Disclosure of Information) Regulations 2018, how many times his Department has sought information relating to bespoke medicines from small producers with an annual NHS turnover of less than £5 million; and whether he plans to make an assessment on the potential merits of requiring all small producers to automatically supply quarterly information on those medicines. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris remove filter
star this property uin 252063 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-13more like thismore than 2019-05-13
star this property answer text <p>The Health Service Products (Provision and Disclosure of Information) Regulations 2018 (the Regulations) prescribe when manufacturers, importers and wholesalers of special medicinal products are required to provide information. Since the Regulations entered into force, quarterly information has been received in November 2018 and February 2019 and information is again due at the end of May 2019. The requirement to provide quarterly sales, purchase and volume information about special medicinal products already applies to all manufacturers, importers and wholesalers regardless of their size. Therefore, there is no need for an assessment on the potential merits of requiring all small producers to automatically supply quarterly information.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 252064 more like this
star this property question first answered
less than 2019-05-13T15:40:15.87Zmore like thismore than 2019-05-13T15:40:15.87Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1125381
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to the Health Service Products (Provision and Disclosure of Information) Regulations 2018, what criteria his Department uses to decide on which small producers to seek information from. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris remove filter
star this property uin 252064 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-13more like thismore than 2019-05-13
star this property answer text <p>The Health Service Products (Provision and Disclosure of Information) Regulations 2018 (the Regulations) prescribe when manufacturers, importers and wholesalers of special medicinal products are required to provide information. Since the Regulations entered into force, quarterly information has been received in November 2018 and February 2019 and information is again due at the end of May 2019. The requirement to provide quarterly sales, purchase and volume information about special medicinal products already applies to all manufacturers, importers and wholesalers regardless of their size. Therefore, there is no need for an assessment on the potential merits of requiring all small producers to automatically supply quarterly information.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 252063 more like this
star this property question first answered
less than 2019-05-13T15:40:15.92Zmore like thismore than 2019-05-13T15:40:15.92Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1125382
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, with reference to the Health Service Products (Provision and Disclosure of Information) Regulations 2018, what steps he is taking to ensure that (a) wholesalers and (b) importers are providing his Department with information on medicines. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris remove filter
star this property uin 252065 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-13more like thismore than 2019-05-13
star this property answer text <p>The Department is undertaking an exercise to ensure that all companies that are required to provide quarterly information under the Health Service Products (Provision and Disclosure of Information) Regulations 2018 (the Regulations) are doing so. Where they are not, the Department will consider taking the appropriate action provided for in the Regulations.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-05-13T15:39:14.28Zmore like thismore than 2019-05-13T15:39:14.28Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1125383
star this property registered interest false more like this
star this property date less than 2019-05-08more like thismore than 2019-05-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when he plans to use the powers set out in the Health Service Products (Provision and Disclosure of Information) Regulations 2018 to seek information on the special health service medicine selected yy medical professional bodies. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris remove filter
star this property uin 252066 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-13more like thismore than 2019-05-13
star this property answer text <p>The Department selects medicines to be included in the quarterly collection of information on special medicinal products based on the level of prescribing. If medical professional bodies have selected special medicinal products that they believe should be included with a reimbursement price in Part VIIIB of the Drug Tariff then the Department will consider including those products in the quarterly collection, but only if those products are prescribed in primary care. If products are not prescribed in primary care then there is no sales, purchase and volume information for special medicinal products supplied to primary care that can be provided by suppliers in the quarterly information collection.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-05-13T16:08:08.557Zmore like thismore than 2019-05-13T16:08:08.557Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1125053
star this property registered interest false more like this
star this property date less than 2019-05-07more like thismore than 2019-05-07
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Pregnancy: Screening more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what his Department's timetable is for the national roll-out of non-invasive prenatal testing, as recommended by the UK National Screening Committee in November 2016. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris remove filter
star this property uin 251394 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-15more like thismore than 2019-05-15
star this property answer text <p>The procurement for providers to undertake the evaluative roll out of non-invasive prenatal testing (NIPT) in England is currently being undertaken on behalf of Public Health England by NHS England as part of the Genomic Testing Services procurement.</p><p>There has been a legal challenge which relates only to the NIPT element of the current procurement which means that there is currently an automatic suspension in place. The extent of the delay will depend on how the litigation proceeds.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-05-15T16:37:43.49Zmore like thismore than 2019-05-15T16:37:43.49Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1125054
star this property registered interest false more like this
star this property date less than 2019-05-07more like thismore than 2019-05-07
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Genetics: Health Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether he has plans to undertake a public consultation with stakeholders on the development of the National Genomic Healthcare Strategy. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris remove filter
star this property uin 251395 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-15more like thismore than 2019-05-15
star this property answer text <p>In developing the National Genomic Healthcare Strategy, the Government will undertake wide ranging and comprehensive engagement, involving detailed discussions with patient and public groups, researchers, charities and industry. This will be guided by the National Genomics Board, which oversees the Government’s work to maintain the United Kingdom’s position as the world’s leading centre for genomic medicine and research.</p><p>Although this does not involve a formal public consultation document, patients and the public will be key to developing the strategy, and we will utilise a wide range of existing public and patient engagement groups to do so.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-05-15T15:56:28.347Zmore like thismore than 2019-05-15T15:56:28.347Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1121932
star this property registered interest false more like this
star this property date less than 2019-04-18more like thismore than 2019-04-18
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Cancer: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what progress is being made on the development of the UK CAR-T Cell Therapy Strategy; when stakeholders will be invited to participate in the development of that strategy; and when he plans to publish that strategy. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris remove filter
star this property uin 245799 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-04-25more like thismore than 2019-04-25
star this property answer text <p>The National Health Service in England is one of the first health services in the world to deliver Chimeric Antigen Receptor T Cell (CAR-T) Therapy. The first patient began their treatment in October 2018 for B cell acute lymphoblastic leukaemia. NHS England continues to focus on supporting implementation of these CAR-T products in the first wave of treatment centres, and are preparing for a potential second wave of treatment centres to begin delivering the treatment later in 2019. There are no plans to develop or publish a strategy.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-04-25T14:04:42.39Zmore like thismore than 2019-04-25T14:04:42.39Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this
1108771
star this property registered interest false more like this
star this property date less than 2019-04-01more like thismore than 2019-04-01
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when guidance will be made available to pharmacists on the Serious Medicines Shortage Protocols. more like this
star this property tabling member constituency Newton Abbot more like this
star this property tabling member printed
Anne Marie Morris remove filter
star this property uin 239239 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-04-04more like thismore than 2019-04-04
star this property answer text <p>Serious Shortage Protocols are an additional tool to manage and mitigate medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p> </p><p>Operational guidance is still being developed with stakeholders, including where any protocol(s) would be published. The use of a Serious Shortage Protocol has not, to date, been required.</p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property grouped question UIN
239240 more like this
239241 more like this
star this property question first answered
less than 2019-04-04T11:10:59.253Zmore like thismore than 2019-04-04T11:10:59.253Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4249
unstar this property label Biography information for Anne Marie Morris more like this